Literature DB >> 3744051

Production of antibody-tagged enzymes by myeloma cells: application to DNA polymerase I Klenow fragment.

G T Williams, M S Neuberger.   

Abstract

Myeloma DNA expression systems can be used for the synthesis and secretion of antibody/enzyme recombinant molecules. Here we describe the construction of a myeloma cell-line that secretes a hapten-specific antibody/enzyme hybrid molecule, in which the antibody Fc portion has been replaced by the Klenow fragment of Escherichia coli DNA polymerase I (PolIk). This Fab-PolIk hybrid molecule is secreted in good yield from the myeloma transfectants, can be purified to homogeneity in a single step on hapten-Sepharose columns, and exhibits PolIk activity as judged by its use in dideoxy nucleotide sequencing. Thus Fab-PolIk can be used for the same purposes as conventional PolIk but has the advantage that it is easily purified to homogeneity in a one-step purification from culture medium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3744051     DOI: 10.1016/0378-1119(86)90223-4

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Recombinant antibody-metallothionein: design and evaluation for radioimmunoimaging.

Authors:  C Das; P V Kulkarni; A Constantinescu; P Antich; F R Blattner; P W Tucker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

Review 2.  The second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications.

Authors:  J Braun; A Saxon; R Wall; S L Morrison
Journal:  West J Med       Date:  1992-08

3.  Expression of foreign genes in mammalian cells using an antibody fusion system.

Authors:  S J Forster; F J Carr; W J Harris; A A Hamilton
Journal:  Mol Biotechnol       Date:  1994-06       Impact factor: 2.695

4.  Construction and expression of a recombinant antibody-targeted plasminogen activator.

Authors:  J M Schnee; M S Runge; G R Matsueda; N W Hudson; J G Seidman; E Haber; T Quertermous
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

5.  Humanization of immunotoxins.

Authors:  S M Rybak; H R Hoogenboom; H M Meade; J C Raus; D Schwartz; R J Youle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

6.  Metal-binding chimeric antibodies expressed in Escherichia coli.

Authors:  J R Sawyer; P W Tucker; F R Blattner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

Review 7.  Rational immunotherapy with ribonuclease chimeras. An approach toward humanizing immunotoxins.

Authors:  S M Rybak; H R Hoogenboom; D L Newton; J C Raus; R J Youle
Journal:  Cell Biophys       Date:  1992 Aug-Dec

8.  Molecular and functional characterisation of a fusion protein suited for tumour specific prodrug activation.

Authors:  K Bosslet; J Czech; P Lorenz; H H Sedlacek; M Schuermann; G Seemann
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.